A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens

NCT01762514 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Neoplasms
Salivary Gland Diseases
Bone Marrow Diseases
Mucositis

Interventions

DRUG: Amifostine every-other-day regimen
DRUG: Amifostine everyday regimen

Sponsor

Sun Yat-sen University

Collaborators

[object Object]